176 related articles for article (PubMed ID: 20397181)
1. Simultaneous (19)F NMR screening of prolyl oligopeptidase and dipeptidyl peptidase IV inhibitors.
Kichik N; Tarragó T; Giralt E
Chembiochem; 2010 May; 11(8):1115-9. PubMed ID: 20397181
[TBL] [Abstract][Full Text] [Related]
2. Benzimidazolium salts as small, nonpeptidic and BBB-permeable human prolyl oligopeptidase inhibitors.
Tarragó T; Masdeu C; Gómez E; Isambert N; Lavilla R; Giralt E
ChemMedChem; 2008 Oct; 3(10):1558-65. PubMed ID: 18792035
[TBL] [Abstract][Full Text] [Related]
3. The natural product berberine is a human prolyl oligopeptidase inhibitor.
Tarrago T; Kichik N; Seguí J; Giralt E
ChemMedChem; 2007 Mar; 2(3):354-9. PubMed ID: 17295371
[TBL] [Abstract][Full Text] [Related]
4. Identification by 19F NMR of traditional Chinese medicinal plants possessing prolyl oligopeptidase inhibitory activity.
Tarragó T; Frutos S; Rodriguez-Mias RA; Giralt E
Chembiochem; 2006 May; 7(5):827-33. PubMed ID: 16628753
[TBL] [Abstract][Full Text] [Related]
5. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
Deng J; Peng L; Zhang G; Lan X; Li C; Chen F; Zhou Y; Lin Z; Chen L; Dai R; Xu H; Yang L; Zhang X; Hu W
Eur J Med Chem; 2011 Jan; 46(1):71-6. PubMed ID: 21106276
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of verbascoside isolated from Buddleja brasiliensis Jacq. ex Spreng on prolyl oligopeptidase activity.
Filho AG; Morel AF; Adolpho L; Ilha V; Giralt E; Tarragó T; Dalcol II
Phytother Res; 2012 Oct; 26(10):1472-5. PubMed ID: 22275311
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition.
Kirby M; Yu DM; O'Connor S; Gorrell MD
Clin Sci (Lond); 2009 Sep; 118(1):31-41. PubMed ID: 19780719
[TBL] [Abstract][Full Text] [Related]
8. A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors.
Lu IL; Tsai KC; Chiang YK; Jiaang WT; Wu SH; Mahindroo N; Chien CH; Lee SJ; Chen X; Chao YS; Wu SY
Eur J Med Chem; 2008 Aug; 43(8):1603-11. PubMed ID: 18207285
[TBL] [Abstract][Full Text] [Related]
9. Chemical Composition and Inhibitory Effects of Hypericum brasiliense and H. connatum on Prolyl Oligopeptidase and Acetylcholinesterase Activities.
Dos Santos MZ; Dalcol II; Adolpho L; Teixidó M; Tarragó T; Morel A; Giralt E
Med Chem; 2016; 12(5):457-63. PubMed ID: 26497127
[TBL] [Abstract][Full Text] [Related]
10. [Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors].
Han B; Huan Y; Lin ZY; Li P; Shen ZF; Yin DL; Huang HH
Yao Xue Xue Bao; 2010 Nov; 45(11):1379-84. PubMed ID: 21361038
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of structurally constrained imidazolidin derivatives as potent dipeptidyl peptidase IV inhibitors.
Wang L; Zhang B; Ji J; Li B; Yan J; Zhang W; Wu Y; Wang X
Eur J Med Chem; 2009 Aug; 44(8):3318-22. PubMed ID: 19375196
[TBL] [Abstract][Full Text] [Related]
12. Discovery of β-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors.
Park WS; Kang SK; Jun MA; Shin MS; Kim KY; Rhee SD; Bae MA; Kim MS; Kim KR; Kang NS; Yoo SE; Lee JO; Song DH; Silinski P; Schneider SE; Ahn JH; Kim SS
Bioorg Med Chem Lett; 2011 Mar; 21(5):1366-70. PubMed ID: 21306895
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological assay in vitro and molecular docking studies of new imidazopyrazinone derivatives as potential dipeptidyl peptidase IV inhibitors.
Zhu Y; Xia S; Zhu M; Yi W; Cheng J; Song G; Li Z; Lu P
Eur J Med Chem; 2010 Nov; 45(11):4953-62. PubMed ID: 20800322
[TBL] [Abstract][Full Text] [Related]
14. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.
Van der Veken P; Haemers A; Augustyns K
Curr Top Med Chem; 2007; 7(6):621-35. PubMed ID: 17352682
[TBL] [Abstract][Full Text] [Related]
15. Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors.
Tsai TY; Hsu T; Chen CT; Cheng JH; Chiou MC; Huang CH; Tseng YJ; Yeh TK; Huang CY; Yeh KC; Huang YW; Wu SH; Wang MH; Chen X; Chao YS; Jiaang WT
Bioorg Med Chem Lett; 2009 Apr; 19(7):1908-12. PubMed ID: 19269819
[TBL] [Abstract][Full Text] [Related]
16. Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
Tarragó T; Kichik N; Claasen B; Prades R; Teixidó M; Giralt E
Bioorg Med Chem; 2008 Aug; 16(15):7516-24. PubMed ID: 18650094
[TBL] [Abstract][Full Text] [Related]
17. Identification of DPP-IV inhibitory peptides derived from buffalo colostrum: Mining through bioinformatics, in silico and in vitro approaches.
Ashok A; H S A
J Mol Recognit; 2024 Jul; 37(4):e3090. PubMed ID: 38803118
[TBL] [Abstract][Full Text] [Related]
18. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
Al-Masri IM; Mohammad MK; Taha MO
ChemMedChem; 2008 Nov; 3(11):1763-79. PubMed ID: 18989859
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors.
Lam B; Zhang Z; Stafford JA; Skene RJ; Shi L; Gwaltney SL
Bioorg Med Chem Lett; 2012 Nov; 22(21):6628-31. PubMed ID: 23025999
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors.
Ikuma Y; Hochigai H; Kimura H; Nunami N; Kobayashi T; Uchiyama K; Furuta Y; Sakai M; Horiguchi M; Masui Y; Okazaki K; Sato Y; Nakahira H
Bioorg Med Chem; 2012 Oct; 20(19):5864-83. PubMed ID: 22938786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
